Bioequivalence concentrates on for hostile to malarials in the prequalification venture: Outcomes and often experienced

3412 days ago, 1258 views

PowerPoint PPT Presentation

Tanzania, 21.- 25. Admirable. 2. Rundown of Submissions for Anti-Malaria Drugs (May 2006). MonoArtemether i.m. Inj.11Artemether oral 5Artesunate oral 50mg 8Artesunate oral 100 mg 1Artesunate oral 200 mg 2Artesunate rectal 3Artesunate i.v. Inj. 1Dihydroartemisinin oral 1Amodiaquine 2 (N=34).

Presentation Transcript

Slide 1

<html> <head><title>403 Forbidden</title></head> <body> <h1>403 Forbidden</h1> <ul> <li>Code: AccessDenied</li> <li>Message: Access Denied</li> <li>RequestId: 384AQAJGG467RGCQ</li> <li>HostId: qwSNHj2ILNNO98bKs3htkYkEz4Z2baZ6IgTRuMIIdi8LU8r74jyluADt7CVcBNo2TntpxBiMIFBfqDwnK9xpkGJvkHRgsGV7</li> </ul> <hr/> </body> </html>

SPONSORS